Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study-Reference-Cited by-同舟云学术

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

Published:2012-10-29 Issue:4 Volume:31 Page:179-182
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Zinzani Pier Luigi¹,Pellegrini Cinzia¹,Merla Emanuela²,Ballerini Filippo³,Fabbri Alberto⁴,Guarini Attilio⁵,Pavone Vincenzo⁶,Quintini Gerlando⁷,Puccini Benedetta⁸,Vigliotti Maria Luigia⁹,Stefoni Vittorio¹,Derenzini Enrico¹,Broccoli Alessandro¹,Gandolfi Letizia¹,Quirini Federica¹,Casadei Beatrice¹,Argnani Lisa¹,Baccarani Michele¹

Affiliation:

1. Department of Hematology and Oncology ‘L. and A. Seràgnoli’, S. Orsola-Malpighi Hospital; University of Bologna; Italy

2. Unit of Hematology, IRCCS Ospedale Casa Sollievo della Sofferenza; San Giovanni Rotondo; Italy

3. Department of Hematology; Azienda ospedaliero-universitaria San Martino; Genova Italy

4. Department of Hematology; Azienda ospedaliero-universitaria senese; Siena Italy

5. Unit of Oncology and Hematology; IRCCS Ospedale oncologico di Bari; Italy

6. Unit of Hematology; Tricase Italy

7. Unit of Hematology; Policlinico di Palermo; Italy

8. Department of Hematology; Azienda ospedaliero-universitaria Careggi; Firenze Italy

9. Unit of Oncology and Hematology; Azienda ospedaliera San Sebastiano di Caserta; Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference26 articles.

1. Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence;Morschhauser;Oncologist,2009

2. Mantle cell lymphoma;Pileri;Haematologica,2009

3. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappaB;Palombella;Cell,1994

4. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis;Pham;J Immunol,2003

5. Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo;Wang;Leukemia,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review;Frontiers in Oncology;2023-02-07

2. Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial;British Journal of Haematology;2020-03-09

3. Gastrointestinal Involvement in Patients with Mantle Cell Lymphoma: A Single Center Experience of Eighty-Five Patients;Digestive Diseases;2019

4. Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma;Expert Review of Hematology;2017-07-14

5. Weekly versus biweekly bortezomib given in patients with indolent non-Hodgkin lymphoma: A meta-analysis;PLOS ONE;2017-05-22